|
FAM103A1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.764000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.586000E-01 |
| Normal-vs-Stage2 |
6.112000E-01 |
| Normal-vs-Stage3 |
1.382580E-01 |
| Normal-vs-Stage4 |
1.573220E-04 |
| Stage1-vs-Stage2 |
7.890000E-01 |
| Stage1-vs-Stage3 |
1.417590E-01 |
| Stage1-vs-Stage4 |
1.081080E-03 |
| Stage2-vs-Stage3 |
3.963800E-01 |
| Stage2-vs-Stage4 |
6.617400E-03 |
| Stage3-vs-Stage4 |
5.740500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.223600E-01 |
| Normal-vs-AfricanAmerican |
4.846600E-01 |
| Normal-vs-Asian |
1.012380E-01 |
| Caucasian-vs-AfricanAmerican |
9.124000E-01 |
| Caucasian-vs-Asian |
4.765800E-02 |
| AfricanAmerican-vs-Asian |
3.676200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.453000E-01 |
| Normal-vs-Female |
7.244300E-02 |
| Male-vs-Female |
6.118000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.933600E-02 |
| Normal-vs-Extreme_Weight |
8.838800E-01 |
| Normal-vs-Obese |
4.356200E-01 |
| Normal-vs-Extreme_Obese |
2.556600E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.568100E-02 |
| Normal_Weight-vs-Obese |
2.618400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.336500E-02 |
| Extreme_Weight-vs-Obese |
3.036400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.338800E-01 |
| Obese-vs-Extreme_Obese |
2.231800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.962400E-02 |
| Normal-vs-Age(41-60Yrs) |
1.797440E-01 |
| Normal-vs-Age(61-80Yrs) |
7.084400E-01 |
| Normal-vs-Age(81-100Yrs) |
6.805800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.436800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.414570E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.397600E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.465600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.414300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.160410E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.042200E-01 |
| Normal-VS-Type2 PRCC |
9.955400E-01 |
| Normal-VS-KIRP CIMP |
1.318110E-03 |
| Normal-VS-Unclassified PRCC |
8.743800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.776000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.535300E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
7.530000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.469650E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.824600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.097780E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.690200E-01 |
| Normal-vs-N1 |
3.998100E-03 |
| Normal-vs-N2 |
6.653400E-01 |
| N0-vs-N1 |
2.444900E-03 |
| N0-vs-N2 |
7.759600E-01 |
| N1-vs-N2 |
1.385440E-01 |
|
|
